Descriptive characteristics of continuous oximetry measurement in moderate to severe covid-19 patients

被引:0
|
作者
Jonathan A. Sobel
Jeremy Levy
Ronit Almog
Anat Reiner-Benaim
Asaf Miller
Danny Eytan
Joachim A. Behar
机构
[1] Israel Institute of Technology,Faculty of Biomedical Engineering, Technion
[2] Israel Institute of Technology,Faculty of Electrical Engineering, Technion
[3] Rambam Health Care Campus,Department of Epidemiology, Biostatistics and Community Health Sciences, Faculty of Health Sciences
[4] Ben Gurion University of the Negev Beer-Sheva,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Non-invasive oxygen saturation (SpO2) is a central vital sign used to shape the management of COVID-19 patients. Yet, there have been no report quantitatively describing SpO2 dynamics and patterns in COVID-19 patients using continuous SpO2 recordings. We performed a retrospective observational analysis of the clinical information and 27 K hours of continuous SpO2 high-resolution (1 Hz) recordings of 367 critical and non-critical COVID-19 patients hospitalised at the Rambam Health Care Campus, Haifa, Israel. An absolute SpO2 threshold of 93% most efficiently discriminated between critical and non-critical patients, regardless of oxygen support. Oximetry-derived digital biomarker (OBMs) computed per 1 h monitoring window showed significant differences between groups, notably the cumulative time below 93% SpO2 (CT93). Patients with CT93 above 60% during the first hour of monitoring, were more likely to require oxygen support. Mechanical ventilation exhibited a strong effect on SpO2 dynamics by significantly reducing the frequency and depth of desaturations. OBMs related to periodicity and hypoxic burden were markedly affected, up to several hours before the initiation of the mechanical ventilation. In summary, OBMs, traditionally used in the field of sleep medicine research, are informative for continuous assessment of disease severity and response to respiratory support of hospitalised COVID-19 patients. In conclusion, OBMs may improve risk stratification and therapy management of critical care patients with respiratory impairment.
引用
收藏
相关论文
共 50 条
  • [1] Descriptive characteristics of continuous oximetry measurement in moderate to severe covid-19 patients
    Sobel, Jonathan A.
    Levy, Jeremy
    Almog, Ronit
    Reiner-Benaim, Anat
    Miller, Asaf
    Eytan, Danny
    Behar, Joachim A.
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01):
  • [2] Continuous Remote Monitoring in Moderate and Severe COVID-19 Patients
    Rajanna, Avinash H.
    Bellary, Vaibhav S.
    Puranic, Sohani Kashi
    Nayana, C.
    Nagaraj, Jatin Raaghava
    Eshanye, D. A.
    Preethi, K.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [3] Clinical characteristics of Japanese patients with moderate to severe COVID-19
    Otoshi, Ryota
    Hagiwara, Eri
    Kitayama, Takaaki
    Yamaya, Takafumi
    Higa, Katsuyuki
    Murohashi, Kota
    Sato, Yozo
    Tabata, Erina
    Shintani, Ryota
    Okabayashi, Hiroko
    Ikeda, Satoshi
    Niwa, Takashi
    Nakazawa, Atsuhito
    Oda, Tsuneyuki
    Okuda, Ryo
    Sekine, Akiamasa
    Kitamura, Hideya
    Baba, Tomohisa
    Komatsu, Shigeru
    Ogura, Takashi
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2021, 27 (06) : 895 - 901
  • [4] Residual symptoms in moderate to severe COVID-19 patients
    Elfidha, Sabrine
    Louhaichi, Sabrine
    Khalfallah, Ikbel
    Marzouki, Safa
    Kaabi, Line
    Jebeli, Rihab
    Kharrat, Mohamed Ali
    Ammar, Jamel
    Hamdi, Besma
    Hamzaoui, Agnes
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [5] The effect of Fingolimod on patients with moderate to severe COVID-19
    Teymouri, Soheil
    Kaleybar, Siamak Pourbayram
    Hejazian, Seyyed Sina
    Hejazian, Seyyedeh Mina
    Ansarin, Khalil
    Ardalan, Mohammadreza
    Vahed, Sepideh Zununi
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (01):
  • [6] Remdesivir treatment for patients with moderate to severe COVID-19
    Hasanoglu, Imran
    Guner, Rahmet
    Celik, Ilhami
    Kanat, Fikret
    Batirel, Ayse
    Dizman, Gulcin Telli
    Eren, Esma
    Sevgi, Dilek Yildiz
    Bozkurt, Ilkay
    Yasar, Kadriye Kart
    Senoglu, Sevtap
    Kazak, Esra
    Karaali, Ridvan
    Celikbas, Aysel
    Pullukcu, Husnu
    Cagatay, Arif Atahan
    Unal, Serhat
    Erdinc, Sebnem
    Tabak, Fehmi
    Gul, Ahmet
    Alp, Emine
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (04) : 880 - 887
  • [7] Clinical, laboratory and radiological features and outcomes of moderate to severe COVID-19 patients: A descriptive retrospective study
    Nehara, Hardeva Ram
    Agrawal, Sahaj
    Chhimpa, Atma Ram
    Sunil, I. H.
    Arakeri, Avadusidda
    Sirohi, Pramendra
    [J]. JOURNAL OF ACUTE DISEASE, 2021, 10 (02) : 62 - 70
  • [8] Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure
    Brusasco, Claudia
    Corradi, Francesco
    Di Domenico, Antonia
    Raggi, Francesca
    Timossi, Graziano
    Santori, Gregorio
    Brusasco, Vito
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (02)
  • [9] The State of Microcirculatory Hemodynamics in Patients with Moderate and Severe COVID-19
    Kuznik, B., I
    Smolyakov, Yu N.
    Shapovalov, Yu K.
    Shapovalov, K. G.
    Lukyanov, S. A.
    Parts, D. S.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 171 (04) : 453 - 457
  • [10] Cytokine Storm Signature in Patients with Moderate and Severe COVID-19
    Kalinina, Olga
    Golovkin, Alexey
    Zaikova, Ekaterina
    Aquino, Arthur
    Bezrukikh, Vadim
    Melnik, Olesya
    Vasilieva, Elena
    Karonova, Tatiana
    Kudryavtsev, Igor
    Shlyakhto, Evgeny
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)